Possible Anticancer Activity of Rosuvastatine, Doxazosin, Repaglinide and Oxcarbazepin (original) (raw)

Anticancer activity of some commercial antihypertensive drugs by Neutral Red assay

fathia El Sharkawi

View PDFchevron_right

Diltiazem Potentiation of Doxorubicin Cytotoxicity and Cellular Uptake in Ehrlich Ascites Carcinoma Cells

Zoheir Damanhouri

Chemotherapy, 1995

View PDFchevron_right

In vitro assessment of cytotoxic and genotoxic activities of the anticancer drug doxorubicin

Shimaa El-Sayed Rashad

Egyptian Journal of Chemistry, 2024

View PDFchevron_right

Antitumor activity of doxycycline in HepG-2 cells

Mamdouh El-Shishtawy

International Journal of Advanced Research

View PDFchevron_right

Analysis of Antineoplastic Drugs: Clinical Pharmacology and Therapeutic Study

IOSR Journals

View PDFchevron_right

Cytotoxic effects of 110 reference compounds on HepG2 cells and for 60 compounds on HeLa, ECC-1 and CHO cells

Walter Westerink, Willem G.e.j. Schoonen

Toxicology in Vitro, 2005

View PDFchevron_right

Effect of Cremophor EL on the pharmacokinetics, antitumor activity and toxicity of doxorubicin in mice

Mohey Elmazar

Anti-Cancer Drugs, 1998

View PDFchevron_right

Doxazosin: a new cytotoxic agent for prostate cancer?

Çağ Çal

BJU International, 2001

View PDFchevron_right

Interaction between doxorubicin and the resistance modifier stilbene on multidrug resistant mouse lymphoma and human breast cancer cells

Noélia Duarte

Anticancer research

View PDFchevron_right

Preclinical trial on the use of doxycycline for the treatment of adenocarcinoma

Jose Guzman-Esquivel

View PDFchevron_right

Doxorubicin compared with related compounds in a nude mouse model for human ovarian cancer

Herbert Pinedo

European journal of cancer (Oxford, England : 1990), 1990

View PDFchevron_right

The effect of Doxorubicin and Thioridazine on squamous carcinoma cell line

bassant moustafa

2021

View PDFchevron_right

Evaluation of New Anti-Neoplastic Active Ingredient in Vitro

Khalil Halfawy

Bulletin of Pharmaceutical Sciences. Assiut, 2008

View PDFchevron_right

17. New anti cancer agents Recent development in tumor prevention

Ghulam Md Ashraf

View PDFchevron_right

Effect of selected catechins on doxorubicin antiproliferative efficacy and hepatotoxicity in vitro

Petra Matoušková

2014

View PDFchevron_right

Anti-Cancer Agents in Medicinal Chemistry

Christian Hernández Silva

GPER Overexpression in Cervical Cancer Versus Premalignant Lesions: Its Activation Induces Different Forms of Cell Death, 2019

View PDFchevron_right

Ellajik Asidin İnsan Akciğer Kanseri Üzerine Antiproliferatif Etkinliklerinin İn Vitro Araştırılması

Dr. Hüseyin İzgördü

Bilecik Şeyh Edebali Üniversitesi Fen Bilimleri Dergisi

View PDFchevron_right

Modulation of doxorubicin cytotoxicity by resveratrol in a human breast cancer cell line

Mohamed Elshal, Sameer Al-harthi, Zoheir Damanhouri

Cancer Cell International, 2012

View PDFchevron_right

Diltiazem potentiation of doxorubicin cytotoxicity and cellular uptake in human breast cancer cells

Sameer Al-harthi

Breast Cancer Management, 2019

View PDFchevron_right

Evaluation of the Cytotoxic and Apoptogenic Effects of Glabridin and Its Effect on Cytotoxicity and Apoptosis Induced by Doxorubicin Toward Cancerous Cells

Farahnaz Ahmadi

Advanced Pharmaceutical Bulletin, 2019

View PDFchevron_right

ANTI-CANCER MEDICINS (CLASSIFICATION AND MECHANISMS OF ACTION

Hamzah Babkair

EGYPTIAN DENTAL JOURNAL, 2024

View PDFchevron_right

Comparative cellular and molecular analysis of cytotoxicity and apoptosis induction by doxorubicin and Baneh in human breast cancer T47D cells

parisa fathi rezaei

Cytotechnology

View PDFchevron_right

Doxazolidine Induction of Apoptosis by a Topoisomerase II Independent Mechanism

Tad Koch

Journal of Medicinal Chemistry, 2007

View PDFchevron_right

Mode of action of some bioactive compounds with anticancer activity

Great Alabi

Bioactive compounds in health and disease, 2022

View PDFchevron_right

Pharmacological and Toxicological Aspects of 4-Demethoxy-3*-deamino-3*- aziridinyl-4*-methylsulphonyl-daunorubicin (PNU-159548): A Novel Antineoplastic Agent1

Claudio Arrigoni

View PDFchevron_right

Efficacy of 6-Diazo-5-oxo-l-norleucine and N-[N-γ-Glutamyl-6-diazo-5-oxo-norleucinyl]-6-diazo-5-oxo-norleucine against Experimental Tumors in Conventional and Nude Mice

Raphael Catane

Cancer Research, 1979

View PDFchevron_right

Specific antioxidant compounds differentially modulate cytotoxic activity of doxorubicin and cisplatin: in vitro and in vivo study

Valery Gurinovich

Croatian Medical Journal, 2014

View PDFchevron_right

The Cytotoxic and Antimigratory Activity of Brazilin-Doxorubicin on MCF-7/HER2 Cells

Universitas Gadjah Mada

View PDFchevron_right

Cytotoxic effects of new synthesis heterocyclic derivatives of Amoxicillin on some cancer cell lines

Mohammad Al-Halbosiy

Journal of Physics: Conference Series, 2018

View PDFchevron_right